Biologics License Application (BLA)

Kimberly Redmond | |

Moderna Inc (Nasdaq: MRNA) is asking the US Food and Drug Administration (FDA) for full approval of its COVID-19 vaccine for people age 18 and up, the company announced Tuesday.

The Massachusetts-based drugmaker began distributing its experimental double-dose vaccine in December 2020 under an FDA emergency use authorization (EUA), a temporary approval from regulators that requires only two months of clinical data.